All single peptides A to Z30 peptides, with a chart for each vial size
All blendsA blend is two or more peptides mixed in one vial.
All stacksA stack is two separate vials used together. Each page gives both draws.
All guidesEvery tool runs in your browser. Nothing you type is sent anywhere.
| Peptide | Where the doses come from | How often | US | Canada |
|---|---|---|---|---|
| Thymosin Alpha-1 | Reported range, not a label dose | Twice weekly | Not approved | Not authorized |
| LL-37 | Reported range, not a label dose | Daily to 3 times weekly | Not approved | Not authorized |
| Vilon | Reported range, not a label dose | Once daily | Not approved | Not authorized |
US Not approved Canada Not authorized
The range reported for thymosin alpha-1 is 1.5 to 1.6 mg twice a week. The Italian Zadaxin label gives one 1.6 mg vial twice a week for four weeks, as an add-on to flu vaccination. It is not approved in the US or Canada, and the largest trial, in sepsis, found no drop in deaths.
US Not approved Canada Not authorized
The range reported for LL-37 is 100 to 250 mcg a day. No human study has injected LL-37 under the skin. In people it has been put on leg ulcers and, in one very small trial, injected into tumours. It is not approved in the US or Canada.
US Not approved Canada Not authorized
Vilon has been given to patients in a few small Russian studies, but their published abstracts state no dose. The 100 mcg to 2 mg a day that people report comes from sellers and users, not from a trial. It is not an approved medicine in the US or Canada, so there is no label dose.
Weight loss and metabolicHealing and recoveryGrowth hormoneLongevityBrain and focusSkin and hairHormonal and sexual healthBlendsAll dosages A to Z
DosageFacts is an information site. It is not medical advice. Talk to a licensed professional before using any medication.